Skip to content
HW191211 5th Annual PREDiCT 3D Oncology & Tissue Models Summit logo

September 2021

  • Home
  • About
    • About Event
    • About PREDiCT
    • Interactive Virtual Experience
    • Testimonials
    • Content Library
    • Digital FAQs
  • Program
    • 2020 Event Guide
    • 2020 Speaker Faculty
    • Agenda
      • 2020 Day One
      • 2020 Day Two
  • Partnerships
    • Partnership Opportunities
    • 2020 Partners
    • 2020 Media Partners
    • PREDiCT Series Prospectus
  • Get involved
    • Register
    • Contact us

StemoniX

By jacobsa | 15th May 2019

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells in high density plates. We develop and manufacture human induced pluripotent stem cell-derived cardiac and neuronal platforms for high throughput drug toxicity and efficacy screening. Predictive, accurate, and consistent, our human models enable scientists to economically conduct research in a simplified workflow. StemoniX microHeart® products provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity, essential in predicting drug toxicity and efficacy. We also collaborate with drug discovery organizations to operationalize their human cells for drug screening.

OUR CONTACT DETAILS

E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

This meeting ran digitally on September 30 – October 1.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok